2D-BioPAD

In a Nutshell

2D-BioPAD is pioneering a graphene-based Point-of-Care (PoC) In-Vitro Diagnostics (IVD) system for early Alzheimer’s Disease (AD) detection. This non-invasive solution, using 2D materials, can identify and quantify up to 5 AD biomarkers in real-time. Clinical pilot studies in Finland, Greece, and Germany aim to demonstrate its impact, with a focus on safety, ethics, and seamless integration into primary healthcare settings.

Latest News

2D-BioPAD at the one-day conference “Dementia Forum – Informing the citizens of Kilkis

On December 15th, 2024, the One-day conference “Dementia Forum – Informing the Citizens of Kilkis” took place at...

Interview with Prof. Arben Merkoçi (ICN2) – Graphene Week 2024

During Graphene Week 2024, Prof. Arben Merkoçi from the Catalan Institute of Nanoscience and Nanotechnology (ICN2) gave an...

2D-BioPAD at Know4Nano workshop

Dr. Marianna Rossetti participated in the Know4Nano workshop, held at the Biosense Institute in Novi Sad from November...

Artificial Intelligence – Re-engineering graphene-based biosensors

Artificial Intelligence (AI), a rapidly advancing field of computer science, focuses on developing software and systems capable of...

All news

Supple Graphene Bio-Platform for point-of-care early detection and monitoring of Alzheimer’s Disease.